The Prognostic Significance of Phosphatase and Tensin Homolog Loss in Breast Cancer
Article in Open Access Macedonian Journal of Medical Sciences (October 2019)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Combination of the mTOR Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical Trial
Article in Clinical Cancer Research (January 2015)
PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target
Article in Journal of Clinical Investigation (November 2011)